Related Articles

News
STAT+: Early cancer-detection market heats up as Guardant Health launches colon cancer test
May 2, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Early cancer-detection market heats up as Guardant Health launches colon cancer test
Guardant Health announced the commercial launch of its early-detection colon cancer test, marking the latest twist in an escalating race to spot cancer sooner and more accurately. […]

News
STAT+: Up and down the ladder: The latest comings and goings
April 1, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. […]

News
STAT+: Bristol Myers agrees to settle lawsuit alleging anti-competitive deals involving HIV drugs
April 14, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Bristol Myers agrees to settle lawsuit alleging anti-competitive deals involving HIV drugs
Bristol Myers Squibb has agreed to pay up to $11 million to settle a lawsuit that accused several drugmakers of conspiring to block generic competition to HIV medicines. […]